Olysio® (simeprevir) – Drug discontinuation
April 20, 2018 - Janssen announced the discontinuation of Olysio (simeprevir) due to a significant decline in utilization and the availability of effective therapies, such as pangenotypic combination regimens, which address the current medical need in treating hepatitis C virus (HCV) infection.
Top